69 results
Posted on 19.04.2021
Healthcare’s future starts now
As the old saying goes, making predictions can be difficult – especially about the future. If you need evidence of this, think how you might have answered the question ‘Where do you see yourself in five years’ time?’ if you had been asked in 2016. But while the pandemic has delivered a harsh lesson in […]
Posted on 15.03.2021
VIP access: a proposal for a new model for embracing healthcare innovation
High-value innovations in care delivery play an essential role in solving the challenges facing Europe’s health system. However, ensuring adoption and uptake of new technology solutions is far from simple. Current reimbursement and access models have served Europe well but are now reaching their limit in ensuring timely patient access to truly cutting-edge technologies and […]
Posted on 02.02.2021
Biobanks and medtech: an underdeveloped partnership
Unlocking academia-industry collaboration on sample collection, storage and sharing COVID-19 has demonstrated that access to quality samples and clinical data is key to facing any healthcare challenge. Millions of people have been tested around the world, generating an enormous number of samples and patients’ data. Of course, swabs can have a life after the results […]
Posted on 28.01.2021
Answering the Call of Telehealth
Even before the COVID-19 pandemic, video consultations were on the rise, with many healthcare systems advocating a digital-first approach. In patient care and clinical trials, demand for virtual care has never been higher. The pandemic has accelerated this shift. For me, it has been exciting to collaborate with health systems at a time of urgent […]
Posted on 20.10.2020
In crisis, medtech found the path to realise its full potential
I have been truly humbled by the collective response of the medical technology industry through this pandemic. As we approach MedTech Week 2020, our industry can be proud of the contribution we have made. But as we reflect on the impact of this unprecedented year, perhaps the true legacy has yet to reveal itself: how […]
Posted on 21.09.2020
EU Health PPP: a new era for medtech companies
For decades, companies in the medtech and pharma sectors have delivered healthcare innovations separately – collaboration has been limited. However, we know that this is not how patients experience healthcare. In the real world, diagnostics, devices, medicines, vaccines and digital tools combine to keep people healthy and to treat those who are unwell. This reality […]
Posted on 05.06.2020
How a focus on efficiency can help treat more atrial fibrillation patients
This blog is part of a blog series that showcases the medtech role in the different phases of the COVID-19 pandemic. Read here more COVID-19 related blogs. More info on MedTech Europe’s info hub. Before COVID-19 hit, there were around 11 million people across Europe living with atrial fibrillation (AF). As many as one in four […]
Posted on 19.03.2020
Horizon Europe: 6 priorities for health Research & Innovation
What key health questions should EU Research & Innovation (R&I) funding aim to address? The Horizon Europe (2021-2027) Health Cluster has provided an answer – well, six answers – which will shape R&I for most of the coming decade. This will also drive my own work in leading the R&I Partnership Policy of MedTech Europe. […]
Posted on 10.02.2020
AI in medical technologies: prioritising an ethical approach to deliver better care
Artificial intelligence (AI) has enormous potential to improve patient outcomes and reduce their variability, making health systems more efficient. But we must take an ethical approach to ensure sustainable implementation and public trust. As leaders in the medical technology sector, we are playing our part in ensuring that our industry develops advanced data-driven technologies […]